BioSpace News Archive

The industry analysis report is considered a valuable source of information about the global Gonorrhea Testing industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, provided a corporate update.

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that preclinical data on AAV204, a novel adeno-associated virus (AAV) capsid from Abeona’s in-licensed AIM™ capsid library, will be presented at the Association for Research and Vision in Ophthalmology (ARVO) Annual Meeting.

Representatives of Rafarma Pharmaceuticals, Inc. visited Uzbekistan and discussed the prospects for the company’s development in the territory of the innovative research and production pharmaceutical cluster “Tashkent Pharma Park”.

Lyra Therapeutics, Inc. (Nasdaq: LYRA), today is presenting additional, new data from its LANTERN Phase 2 study of LYR-210 in adult patients with chronic rhinosinusitis (CRS) at the 2022 Combined Otolaryngology Spring Meetings (COSM) being held April 27 – May 1, 2022 in Dallas, Texas.

Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028 Report Highlights.

Global Peptide Therapeutics Market & Clinical Trials Insight 2028 Report findings.

Moderna, Inc. announced its plan to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec that will support a long-term strategic partnership with the Government of Canada to enhance pandemic preparedness.

Pixium Vision SA announces that its audited financial statements for the year 2021 have been made available on the company’s website.

Increasing launch of cost-efficient generic epinephrine products, growing incidence of anaphylaxis, and rising demand for epinephrine injections to treat cardiac arrest and asthma are some key factors driving market growth.